Etcembly Appoints Scott Cuthill as Chief Business Officer
Etcembly Appoints Scott Cuthill as Chief Business Officer. The Oxford based company is transforming TCR immunotherapy research.
Etcembly Appoints Scott Cuthill as Chief Business Officer
Research Complex at Harwell welcomes Etcembly
Etcembly establishes new lab & office space at Oxford Science Park
Zelluna Immunotherapy AS Announces Exclusive Research Collaboration with Etcembly Limited
Oxford-based machine learning start-up Etcembly secures Private Seed Funding